drugset / Trial / NCT01472757

Clinical Study to Evaluate the Efficacy of VR506 Using a New Inhaler for the Treatment of Asthma

NCT01472757 ↗

Phase 2/3 Completed 374 enrolled Vectura Limited
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of the study is to evaluate the clinical efficacy of three doses of VR506 delivered via a new dry powder inhaler for the treatment of asthma.

Timeline

Start
2011-10
Primary completion
2013-05
Completion
2013-05

Drugs

EvaluationDrugModalityDoseRoute
Comparator VR506 Unknown — Inhaled

Indications